SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TA2K who wrote (3492)6/2/2000 12:08:00 PM
From: TA2K  Read Replies (1) of 3725
 
Okay, here's the big NEWS you want!!!

Imatron applied this last week for FDA approval to market their scanners for EB-Endoscopy, and that covers pretty much the ***entire*** body. Now they can scan, at 10X the speed of any other scanner on the market!, pretty much ***any*** part of the body.

The PR regarding the above paragraph would easily send IMAT into the double digits.

Robin Kelley has told me, however, that it has been Imatron's policy not to publicly announce FDA **applications** --- only application **approval**.

I very strongly disagree with that policy. At this point in time, Imatron needs to get out the PR that discusses the first paragraph above. It is huge, huge, huge news.

Please try to convince Robin, or CEO Lewis Meyer himself, of your view on this:

Robin Kelley [rkelley@imatron.com]
Imatron Investor Relations
800-367-6545

You want news? You want IMAT in quick double digits? There it is.

Stay tuned!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext